| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $269.8M | -21.1% |
| Cost of Revenue | $258.7M | +66.7% |
| R&D Expense | $110.2M | +16.9% |
| SG&A Expense | $493.6M | +91.5% |
| Operating Income | -$569.0M | -220.3% |
| Interest Expense | $24.7M | -3.4% |
| Pre-tax Income | -$538.6M | -93.0% |
| Income Tax | -$2.7M | +66.8% |
| Net Income | -$528.5M | -95.0% |
| EPS (Basic) | -$1.65 | -77.4% |
| EPS (Diluted) | -$1.69 | -74.2% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $64.4M | -86.7% |
| Inventory | $111.9M | +49.0% |
| Current Assets | $306.4M | -52.1% |
| Total Assets | $824.9M | -13.6% |
| Current Liabilities | $387.1M | +43.5% |
| Long-term Debt | $893.0M | +114.0% |
| Total Liabilities | $1.29B | +91.5% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$525.9M | -190.0% |
| Investing Cash Flow | -$123.7M | -93.0% |
| Financing Cash Flow | $231.4M | -67.0% |
| Stockholders' Equity |
| -$488.7M |
| -298.3% |